Statins and myotoxicity: a therapeutic limitation

scientific article published on September 2006

Statins and myotoxicity: a therapeutic limitation is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1517/14740338.5.5.651
P8608Fatcat IDrelease_u3l6go5hsnd6bp75f3iauk5zdu
P698PubMed publication ID16907655

P2093author name stringAnita Chugh
Atul Tiwari
Vinay Bansal
Kasim Mookhtiar
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)651-666
P577publication date2006-09-01
P1433published inExpert Opinion on Drug SafetyQ5421206
P1476titleStatins and myotoxicity: a therapeutic limitation
P478volume5

Reverse relations

cites work (P2860)
Q47360791Adjuvant Statin Therapy for Esophageal Adenocarcinoma: A Cost-Utility Analysis.
Q92031707Analysis of secondary care data to evaluate the clinical relevance of the drug-drug interaction between amlodipine and simvastatin
Q37765562Atorvastatin: safety and tolerability
Q36637890Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
Q41488405Effects of prior treatment with simvastatin on skeletal muscle structure and mitochondrial enzyme activities during early phases of sepsis
Q35970280Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine
Q50054110Genetic variation in statin intolerance and a possible protective role for UGT1A1.
Q38196938High-content analysis in toxicology: screening substances for human toxicity potential, elucidating subcellular mechanisms and in vivo use as translational safety biomarkers
Q50103684Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
Q58567872Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment
Q46082567Metformin and atorvastatin reduce adhesion formation in a rat uterine horn model.
Q37826757Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review
Q42954250Novel role of Cdc42 and RalA GTPases in TNF-α mediated secretion of CCL2.
Q39664282Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model
Q31131725Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
Q24603957Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism
Q91713364Statin-Associated Muscle Disease: Advances in Diagnosis and Management
Q36748508Strategies to reduce late-stage drug attrition due to mitochondrial toxicity
Q36378125The Effect of Atorvastatin on Habitual Physical Activity among Healthy Adults
Q79633194The use of statins in postoperative adhesion prevention

Search more.